Product
neostigmine/glycopyrrolate
Name
Neostigmine
INN Name
Neostigmine
FDA Approved
Yes
2 clinical trials
2 organizations
3 indications
1 document
Indication
Neuromuscular BlockadeIndication
Chronic Obstructive Pulmonary DiseaseIndication
ResidualClinical trial
Comparison of Time to Full Recovery From Muscle Paralysis (TOF>0.9) and Extubation Using Sugammadex Versus Neostigmine/Glycopyrrolate in Patients With Pulmonary Disease in the Outpatient Bronchoscopy SuiteStatus: Completed, Estimated PCD: 2023-07-30
Clinical trial
A Blinded Randomized Study of Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Patients (≥ 75 Years)Status: Recruiting, Estimated PCD: 2024-10-01
Organization
Dr.Reddy's Laboratories IncOrganization
Medical Purchasing Solutions, LLC